Show simple item record

dc.creatorTobar,Marco
dc.creatorBasante,Roberto
dc.creatorGuerrero,María
dc.date2017-01-01
dc.date.accessioned2019-04-25T12:48:34Z
dc.date.available2019-04-25T12:48:34Z
dc.identifierhttps://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0718-85602017000200006
dc.identifier.urihttp://revistaschilenas.uchile.cl/handle/2250/62275
dc.descriptionEndomyocardial fibrosis is a known and prevalent cause of restrictive cardiomyopathy in countries of Equatorial Africa, but very rare elsewhere. Although the diagnosis in endemic countries is established by the presence of certain echocardiographic criteria, the gold standard is the endomyocardial biopsy, which shows fibrous tissue in the endocardium. An acute and subacute phase can be distinguished, with associated mortality due to complications of heart failure. In contrast, the chronic phase presents less aggressive behavior, with progression of symptoms. In this phase, surgical treatment may improve survival. We present the case of a 44-year-old patient with good clinical control under pharmacological treatment after 14 months of follow-up.
dc.formattext/html
dc.languagees
dc.publisherSociedad Chilena de Cardiología y Cirugía Cardiovascular
dc.relation10.4067/S0718-85602017000200006
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceRevista chilena de cardiología v.36 n.2 2017
dc.subjectEndomyocardial fibrosis
dc.subjectrestrictive cardiomyopathy
dc.subjectheart failure
dc.titleFibrosis endomiocárdica crónica, reporte de caso en área no endémica


This item appears in the following Collection(s)

Show simple item record